Of relevance, these results provides indirect evidence that explains the associations between high cholesterol, obesity, and postmenopausal BC onset and progression seen in epidemiological studies and supports testing pharmacological drugs that decrease cholesterol metabolism and block CYP27A1 activity in postmenopausal patients with ER+ BC. This evidence concerns the gene CYP27A1 and obesity disorder.